Erasmus Bachus

5.3k total citations
39 papers, 494 citations indexed

About

Erasmus Bachus is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Erasmus Bachus has authored 39 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Surgery. Recurrent topics in Erasmus Bachus's work include Cardiovascular Function and Risk Factors (14 papers), Heart Failure Treatment and Management (12 papers) and Diabetes Treatment and Management (8 papers). Erasmus Bachus is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Heart Failure Treatment and Management (12 papers) and Diabetes Treatment and Management (8 papers). Erasmus Bachus collaborates with scholars based in Sweden, United States and United Kingdom. Erasmus Bachus's co-authors include Martin Magnusson, Hannes Holm, Artur Fedorowski, Amra Jujić, Olle Melander, John Molvin, Katarina Nägga, Peter M. Nilsson, Fabrizio Ricci and Viktor Hamrefors and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Erasmus Bachus

37 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erasmus Bachus Sweden 15 280 133 64 58 53 39 494
Hakan Akıllı Türkiye 13 232 0.8× 83 0.6× 43 0.7× 54 0.9× 55 1.0× 45 484
Hannes Holm Sweden 13 307 1.1× 185 1.4× 48 0.8× 45 0.8× 129 2.4× 35 525
Janis M. Nolde Australia 12 258 0.9× 87 0.7× 19 0.3× 43 0.7× 38 0.7× 56 475
Henrik Vase Denmark 14 265 0.9× 72 0.5× 118 1.8× 32 0.6× 79 1.5× 31 499
Irina Uphoff United States 7 215 0.8× 61 0.5× 27 0.4× 67 1.2× 34 0.6× 13 463
Praveen Veerabhadrappa United States 12 366 1.3× 55 0.4× 25 0.4× 97 1.7× 45 0.8× 21 563
Amra Jujić Sweden 17 403 1.4× 140 1.1× 80 1.3× 113 1.9× 69 1.3× 61 793
Charlotte van Noord Netherlands 13 270 1.0× 94 0.7× 34 0.5× 31 0.5× 70 1.3× 32 607
Ioannis Andrikou Greece 12 330 1.2× 98 0.7× 26 0.4× 59 1.0× 66 1.2× 55 540
Dan Zhou China 14 208 0.7× 56 0.4× 25 0.4× 100 1.7× 41 0.8× 50 506

Countries citing papers authored by Erasmus Bachus

Since Specialization
Citations

This map shows the geographic impact of Erasmus Bachus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erasmus Bachus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erasmus Bachus more than expected).

Fields of papers citing papers by Erasmus Bachus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erasmus Bachus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erasmus Bachus. The network helps show where Erasmus Bachus may publish in the future.

Co-authorship network of co-authors of Erasmus Bachus

This figure shows the co-authorship network connecting the top 25 collaborators of Erasmus Bachus. A scholar is included among the top collaborators of Erasmus Bachus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erasmus Bachus. Erasmus Bachus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mingming, Toru Kondo, Atefeh Talebi, et al.. (2024). Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction. European Journal of Heart Failure. 26(7). 1524–1538. 6 indexed citations
2.
Davis, Jason A., David T. Booth, Phil McEwan, et al.. (2024). Cost-Effectiveness of Dapagliflozin for Patients with Heart Failure Across the Spectrum of Ejection Fraction: A Pooled Analysis of DAPA-HF and DELIVER Data. European Journal of Heart Failure. 26(3). 664–673. 4 indexed citations
3.
Kondo, Toru, Jawad H. Butt, James P. Curtain, et al.. (2023). Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Circulation Heart Failure. 16(12). e010898–e010898. 3 indexed citations
4.
Gudmundsson, Petri, John Molvin, Erasmus Bachus, et al.. (2023). Galectin-4 is associated with diabetes and obesity in a heart failure population. Scientific Reports. 13(1). 20285–20285. 4 indexed citations
5.
Butt, Jawad H., Henri Lu, Toru Kondo, et al.. (2023). Heart Failure, Chronic Obstructive Pulmonary Disease and Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from DELIVER. European Journal of Heart Failure. 25(11). 2078–2090. 10 indexed citations
6.
Booth, David T., Jason A. Davis, Phil McEwan, et al.. (2023). The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial. European Journal of Heart Failure. 25(8). 1386–1395. 7 indexed citations
7.
Holm, Hannes, Amra Jujić, Olle Melander, et al.. (2022). Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project. Cardiovascular Diabetology. 21(1). 125–125. 5 indexed citations
8.
Holm, Hannes, Marcus Ohlsson, John Molvin, et al.. (2022). The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation—The HARVEST-Malmö study. Frontiers in Cardiovascular Medicine. 9. 982871–982871. 6 indexed citations
9.
Nilsson, Peter M., Olle Melander, Mathias J. Gerl, et al.. (2021). Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort. Journal of Obesity. 2021. 1–9. 5 indexed citations
10.
Grubb, Anders, Amra Jujić, Erasmus Bachus, et al.. (2021). The Shrunken Pore Syndrome is Associated with Poor Prognosis and Lower Quality of Life in Heart Failure Patients: The HARVEST-Malmö Study. ESC Heart Failure. 8(5). 3577–3586. 15 indexed citations
11.
Holm, Hannes, Erasmus Bachus, Amra Jujić, et al.. (2020). Cognitive Test Results are Associated with Mortality and Rehospitalization in Heart Failure: Swedish Prospective Cohort Study. ESC Heart Failure. 7(5). 2948–2955. 44 indexed citations
12.
Holm, Hannes, Martin Magnusson, Per Wollmer, et al.. (2020). Impaired Cerebral Oxygenation in Heart Failure Patients at Rest and During Head-Up Tilt Testing. ESC Heart Failure. 8(1). 586–594. 5 indexed citations
13.
Molvin, John, Amra Jujić, Erasmus Bachus, et al.. (2019). Cardiovascular Biomarkers Predict Post-Discharge Re-Hospitalization Risk and Mortality Among Swedish Heart Failure Patients. ESC Heart Failure. 6(5). 992–999. 26 indexed citations
14.
Bachus, Erasmus, et al.. (2019). Metabolically healthy obesity (MHO) in the Malmö diet cancer study – Epidemiology and prospective risks. Obesity Research & Clinical Practice. 13(6). 548–554. 21 indexed citations
15.
Holm, Hannes, Erasmus Bachus, Fabrizio Ricci, et al.. (2019). Cerebral Oximetry in Syncope and Syndromes of Orthostatic Intolerance. Frontiers in Cardiovascular Medicine. 6. 171–171. 16 indexed citations
16.
Bachus, Erasmus & Piotr Ponikowski. (2019). Beta-3 Receptor Agonists. SHILAP Revista de lepidopterología. 18.
17.
Chau, Kénora, Nicolas Girerd, Martin Magnusson, et al.. (2018). Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort. Clinical Research in Cardiology. 107(10). 887–896. 14 indexed citations
18.
Holm, Hannes, Katarina Nägga, Erik Nilsson, et al.. (2017). N-Terminal Prosomatostatin and Risk of Vascular Dementia. Cerebrovascular Diseases. 44(5-6). 259–265. 7 indexed citations
19.
Holm, Hannes, John Molvin, Erasmus Bachus, et al.. (2017). Autonomic Dysfunction is Associated with Cardiac Remodelling in Heart Failure Patients. ESC Heart Failure. 5(1). 46–52. 23 indexed citations
20.
Holm, Hannes, Katarina Nägga, Erik Nilsson, et al.. (2017). Longitudinal and postural changes of blood pressure predict dementia: the Malmö Preventive Project. European Journal of Epidemiology. 32(4). 327–336. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakan Akıllı Breakdown of academic impact, for papers by Hannes Holm Breakdown of academic impact, for papers by Janis M. Nolde Breakdown of academic impact, for papers by Henrik Vase Breakdown of academic impact, for papers by Irina Uphoff Breakdown of academic impact, for papers by Praveen Veerabhadrappa Breakdown of academic impact, for papers by Amra Jujić Breakdown of academic impact, for papers by Charlotte van Noord Breakdown of academic impact, for papers by Ioannis Andrikou Breakdown of academic impact, for papers by Dan Zhou
Rankless by CCL
2026